Changes in ionic currents and β-adrenergic receptor signaling in hypertrophied myocytes overexpressing Gαq
Authors:
- 1 July 2000
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 279 (1) , H139-H148
Abstract
Transgenic overexpression of Gαq causes cardiac hypertrophy and depressed contractile responses to β-adrenergic receptor agonists. The electrophysiological basis of the altered myocardial function was examined in left ventricular myocytes isolated from transgenic (Gαq) mice. Action potential duration was significantly prolonged in Gαq compared with nontransgenic (NTG) myocytes. The densities of inward rectifier K+ currents, transient outward K+ currents ( I to), and Na+/Ca2+ exchange currents were reduced in Gαq myocytes. Consistent with functional measurements, Na+/Ca2+ exchanger gene expression was reduced in Gαq hearts. Kinetics or sensitivity of I to to 4-aminopyridine was unchanged, but 4-aminopyridine prolonged the action potential more in Gαq myocytes. Isoproterenol increased L-type Ca2+ currents ( I Ca) in both groups, with a similar EC50, but the maximal response in Gαq myocytes was ∼24% of that in NTG myocytes. In NTG myocytes, the maximal increase of I Ca with isoproterenol or forskolin was similar. In Gαq myocytes, forskolin was more effective and enhanced I Ca up to ∼55% of that in NTG myocytes. These results indicate that the changes in ionic currents and multiple defects in the β-adrenergic receptor/Ca2+ channel signaling pathway contribute to altered ventricular function in this model of cardiac hypertrophy.Keywords
This publication has 29 references indexed in Scilit:
- Enhanced Gαq signaling: A common pathway mediates cardiac hypertrophy and apoptotic heart failureProceedings of the National Academy of Sciences of the United States of America, 1998
- Targeting the Receptor-G q Interface to Inhibit in Vivo Pressure Overload Myocardial HypertrophyScience, 1998
- Alterations in calcium handling in cardiac hypertrophy and heart failureCardiovascular Research, 1998
- Transgenic Gαq overexpression induces cardiac contractile failure in miceProceedings of the National Academy of Sciences, 1997
- BASIC DETERMINANTS OF MYOCARDIAL HYPERTROPHY: A Review of Molecular MechanismsAnnual Review of Medicine, 1997
- Evidence for Functional Relevance of an Enhanced Expression of the Na + -Ca 2+ Exchanger in Failing Human MyocardiumCirculation, 1996
- Sarcoplasmic reticulum Ca2+ATPase and phospholamban mRNA and protein levels in end-stage heart failure due to ischemic or dilated cardiomyopathyJournal of Molecular Medicine, 1996
- Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure.Circulation Research, 1993
- Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure.Circulation, 1992
- Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure.Circulation Research, 1987